Issue 10/2020
Special Issue: Radiomics
Content (15 Articles)
Radiomics in radiation oncology—basics, methods, and limitations
Philipp Lohmann, Khaled Bousabarah, Mauritius Hoevels, Harald Treuer
Applications of radiomics and machine learning for radiotherapy of malignant brain tumors
Martin Kocher, Maximilian I. Ruge, Norbert Galldiks, Philipp Lohmann
Radiomic biomarkers for head and neck squamous cell carcinoma
Stephanie Tanadini-Lang, Panagiotis Balermpas, Matthias Guckenberger, Matea Pavic, Oliver Riesterer, Diem Vuong, Marta Bogowicz
Radiomics and deep learning in lung cancer
Michele Avanzo, Joseph Stancanello, Giovanni Pirrone, Giovanna Sartor
Radiomics for liver tumours
Constantin Dreher, Philipp Linde, Judit Boda-Heggemann, Bettina Baessler
The role of radiomics in prostate cancer radiotherapy
Rodrigo Delgadillo, John C. Ford, Matthew C. Abramowitz, Alan Dal Pra, Alan Pollack, Radka Stoyanova
Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas
Xuanwei Zhang, Shuo Liu, Xu Zhao, Xiaobo Shi, Jing Li, Jia Guo, Gabriele Niedermann, Ren Luo, Xiaozhi Zhang
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Davide Franceschini, Luca Cozzi, Fiorenza De Rose, Pierina Navarria, Antonella Fogliata, Ciro Franzese, Donato Pezzulla, Stefano Tomatis, Giacomo Reggiori, Marta Scorsetti
Segmentation of prostate and prostate zones using deep learning
Olmo Zavala-Romero, Adrian L. Breto, Isaac R. Xu, Yu-Cherng C. Chang, Nicole Gautney, Alan Dal Pra, Matthew C. Abramowitz, Alan Pollack, Radka Stoyanova
Cone-beam computed tomography-based radiomics in prostate cancer: a mono-institutional study
Davide Giovanni Bosetti, Lorenzo Ruinelli, Maria Antonietta Piliero, Linda Christina van der Gaag, Gianfranco Angelo Pesce, Mariacarla Valli, Marco Bosetti, Stefano Presilla, Antonella Richetti, Letizia Deantonio
Einfluss der Behandlungscompliance auf den Erfolg der Radiochemotherapie des Analkarzinoms
Daniel Martin, Claus Rödel, Emmanouil Fokas
Vielversprechende Langzeitergebnisse zum Einsatz von Anastrozol zur Prävention von Brustkrebs bei postmenopausalen Hochrisikopatientinnen
Josephin Trabitzsch, Hendrik Schenke
Die Herzmortalität nach Strahlentherapie, Chemotherapie und endokriner Therapie des Mammakarzinoms
Marciana-Nona Duma
Unterschiede in der Lebensqualität über 5 Jahre nach Therapie des lokal begrenzten Prostatakarzinoms mit verschiedenen Behandlungsoptionen
Jan-Hendrik Bolten, Jürgen Dunst